PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) › Capital ExpendituresPROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $5.8K2011: $6.1K2012: $15.9K2013: $6.7K2014: $70.6K2015: $6.1K2017: $30.4K$30.4K2009Capital Expenditures (USD)2017Fiscal YearCapital ExpendituresChange YoY2017$30.4K—2015$6.1K-91.3%2014$70.6K+961.5%2013$6.7K-58.1%2012$15.9K+158.4%2011$6.1K—2009$5.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share